| Tag | Content |
|---|
EnhancerAtlas ID | HS134-03442 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr1:161581710-161583020 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161582212 | 161582506 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | AAAAGTAAGG ATGGAAAACA TACGTTGTCA AAAGTGGGAT TCGAACCCAC GCCTCCAGCG 60
GAGGGTGCGA TTTGAACGCA GCGCCTTAAG ACTGCTCGGC CATCCTGACA CACGTTTTGC 120
TAAACTTCCT AATTTCTCCT AATTTTATCA TATACTGATG GTGCACGCTA TCAGGTCACA 180
TTAATGTGTC TATTTACTGT TTCAAATAAA ATTGTAACTC TCTCTAGACC TTGTCGCAAA 240
GCGGGAAAAA TGAAACAGCC TCCGACAGCT CTTTCCTCTT TCCTCACTAC CCAAACTAAA 300
CCTTAAGGCT CCATTTTCCC TGGCGACTCT TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT 360
CGAGCCATGT CAAGGTAGAC CCTGTGTCGG CCCGTCTCCC TCGGATCCTC CGCACCAATC 420
ACTGTTGCTG AATCCGACAC CCGGCGGATC CAGTGCGGAG TCTCGAACAG CTGCGGAGCT 480
GGGAGCTACG GGACATGAGG AGTGCGGGGG GGAAGAGAAG ACGGCGGAGG AAAATCCCCC 540
GGCGGTGCTC AACTGCGGCT TTCTCTCTCG GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC 600
AGAGCAAGTG GCTTCTGCGT TCACCGCCCC CCGCCGTTTG TGGGGCGGGG CCGATTCATA 660
AGAATCGGTT CTCACCAATG GAGGGCTTAG CATGTTTAAC CTCAGGATCA TAAACAAAAG 720
ACACTGCTAG AACGGTCGGG AAAGTCATAC GCTTTGCTTA TCTTATATAT AGATTTCTAA 780
AATTCCAAAC CGGGGACGCG TTGGTGGTGT AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT 840
TAACGCGGGT TCGATTCCCG GGTAACGAAA CGTTTTTGTC TTTCCTTCTA CGAAAAACTT 900
TTCTGAGCCG GAGCCTCCAG CGCGCTGTGT ATTCGTTTTA CGCCTCAACG AAACTGCAGC 960
AATACCTCAC TTTCCGTACT CGCTTCCTGT CTTTCCCCTG GCCTCTTTCT AAACCCAGGC 1020
TTTTTTTGAA GGGATTAAAT TCTGATGGTT CTTTCCTCCC TTCCTTCCTT TGTAAACTTC 1080
CAACTCTTGA GGAATCTTTG GGATCATTTC AATCCTGGGA TGAGTCTTAG CTTCAGAAAG 1140
GGGCTCTTGT GTCTTCACTT GCGAGGTTCA TTCGCTAGCC TCTACAAATC ATCACTTAAG 1200
CCCCTAATTA TTCCCGGCCG AGGTCCTAGG CTAAGGTCCC GGGCCAAGCT TTCTAATTAG 1260
TCCCAGGCCA AGGTCCCAGG CCAACCTAAA TCACGCATTC TCCAAAACAG 1310
|
